cordycepin has been researched along with dichlororibofuranosylbenzimidazole in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beardmore, C; D'Arpa, P; Liu, LF | 1 |
| Kaufmann, SH | 1 |
| Block, GD; Bogart, B; Khalsa, SB; Whitmore, D | 1 |
| Amaldi, F; Loreni, F; Thomas, G | 1 |
| Abdulle, A; Dirks, RW; Gena, A; Molenaar, C; Tanke, HJ | 1 |
| Cerná, A; Cuadrado, A; De la Torre, C; Díaz de la Espina, SM; Jouve, N | 1 |
6 other study(ies) available for cordycepin and dichlororibofuranosylbenzimidazole
| Article | Year |
|---|---|
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
Topics: Amsacrine; Animals; Antibiotics, Antineoplastic; Aphidicolin; Camptothecin; Cell Survival; Cricetinae; Cricetulus; Cycloheximide; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA; Etoposide; Mutagens; Nucleic Acids; RNA; Time Factors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1991 |
Evidence for a central role of transcription in the timing mechanism of a circadian clock.
Topics: Animals; Circadian Rhythm; Cycloheximide; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Mollusca; Protein Biosynthesis; Purines; Transcription, Genetic | 1996 |
Transcription inhibitors stimulate translation of 5' TOP mRNAs through activation of S6 kinase and the mTOR/FRAP signalling pathway.
Topics: Amanitins; Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cells, Cultured; Dactinomycin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Enzyme Activation; Kidney; Nucleic Acid Synthesis Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Protein Biosynthesis; Protein Kinases; Protein Serine-Threonine Kinases; Ribosomal Protein S6 Kinases; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Transcription, Genetic; Vertebrates; Xenopus laevis; Xenopus Proteins | 2000 |
Poly(A)+ RNAs roam the cell nucleus and pass through speckle domains in transcriptionally active and inactive cells.
Topics: Active Transport, Cell Nucleus; Cell Line; Cell Line, Tumor; Cell Nucleus; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Fluorescence Recovery After Photobleaching; Fluorescent Dyes; Humans; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Oligoribonucleotides; Poly(A)-Binding Protein II; Recombinant Fusion Proteins; Rhodamines; RNA-Binding Proteins; RNA, Messenger; Serine-Arginine Splicing Factors; Transcription, Genetic | 2004 |
Z-DNA, a new in situ marker for transcription.
Topics: Allium; Biomarkers; Cell Nucleus; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; DNA-Directed RNA Polymerases; DNA, Z-Form; Immunohistochemistry; In Situ Hybridization; Transcription, Genetic | 2004 |